William Blair acted as the exclusive M&A advisor to Primed, a portfolio company of Paragon, on its pending sale to Inflexion. The transaction signed July 2026.
About the Companies
Founded in 1946 and based in Halberstadt, Germany, Primed designs, manufactures and distributes essential certified single-use medical consumables. With more than 450 employees and a highly vertically integrated manufacturing platform spanning the entire value chain, from compounding through to the finished sterile product, the company specialises in critical care, surgical and suction products. Primed's products are certified under the European Medical Device Regulation (MDR) and are used by hospitals and healthcare facilities in over 70 countries. In addition to its consumables business, Primed operates one of Europe's largest Ethylene Oxide (EtO) gas sterilisation platforms, providing an essential service to medical device and pharmaceutical companies. Further information is available at www.primed-halberstadt.de.
Paragon is a founder-led private group of companies that invests in established mid-sized companies based in Europe. Paragon works closely with the management teams of its portfolio companies to achieve sustainable growth and operational excellence. Since its foundation in 2004, Paragon has completed more than 50 investments across a broad range of industries. The firm operates from its offices in Munich and Milan and manages more than €2.4 billion of equity capital. Further information is available at www.paragon.de.
Inflexion is a leading European mid-market private equity firm with €20 billion under management investing in high growth, entrepreneurial businesses with ambitious management teams and working in partnership with them to accelerate growth. Inflexion’s flexible approach allows it to make both majority and minority investments in businesses typically valued from €50 million to €1 billion-plus. Read more at www.inflexion.com.
Learn more about our medical technology investment banking expertise.